Today’s top gainers include the company Biogen Inc. (NASDAQ:BIIB) which is in the industry Biotechnology, gaining 0.67% today. In the last week its performance is 2.26%, and -6.54% for the past quarter. Currently, Biogen Inc., BIIB has a target price of 332.47, so today’s gain of 0.67% is a significant step towards its target price. The GAP today is therefore 0.84%.
Biogen Inc. (NASDAQ:BIIB), has a market cap of 55353.24, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 88.50%.
At the current price of 252.87, it has a dividend yield of *TBA, and its target price is 332.47. This is with a profit margin of 33.80%, and total debt/equity of 0.63. Biogen Inc. (NASDAQ:BIIB) has a P/E of 15.53, as well as a forward P/E of 12.56.
With a current EPS of 16.28, and a forecasted EPS growth for next year at 6.56%,Biogen Inc. (NASDAQ:BIIB) has had a EPS growth for the past five years at 31.30%. For the next five years EPS growth is projected to be 7.80%.
Performance for the year is -36.87%. Since its IPO date on 9/17/1991, the total performance to date is -17.46%.
Volume today for Biogen Inc. (NASDAQ:BIIB), is 1293800, while its average volume is 1802.16. Whilst the total gain today was 0.67%, it did have a day high of -13.60%.
Volatility for this week has been at 1.64%, and 2.16% for the month. The 52-week low for Biogen Inc., BIIB has been 13.38%, while the 52-week-high has reached -38.66%.
Looking at its return of investments, which is 23.50%, and its return on assets is 19.00%. Biogen Inc. (NASDAQ:BIIB) has an operating margin of 47.10%. With a sales growth of 6.70% quarter over quarter. Bearing in mind that Biogen Inc., BIIB is in the sector Healthcare, its long-term debt/equity is 0.63, and has a current ratio of 2.6 and 2.2 for quick ratio.
So what is the value of Biogen Inc.? Well its PEG is 1.99, and the P/S is 5.06, along with a P/B of 5.36. Meanwhile it has a p/cash of 15.44.